• Back To Blog

Thomas Lupoli, D.O.

Finally, a New FDA Approved Treatment for Hives

allergy patient questionnaire

Long awaited good news for hive sufferers! The FDA has approved Xolair (omalizumab) for the treatment of chronic hives  (lasting longer than 6 weeks) that are not controlled with antihistamines. This is wonderful news for many people suffering from the debilitating effects of intractable hives. Prior to Xolair,  treatment for refractory hives were limited to  immunosuppressant medications.  Xolair is not first line therapy for hives and not everyone with hives will be a candidate for Xolair. However, it is expected that the FDA’s approval should  improve  insurance coverage and patient access for those who require it.

http://www.medpagetoday.com/Dermatology/Atopy/44880